Martin J. Gilligan
Corporate Officer/Principal bei PHATHOM PHARMACEUTICALS, INC.
Ursprung des Netzwerks ersten Grades von Martin J. Gilligan
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 21 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Martin J. Gilligan
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| CELGENE | Biotechnology | Corporate Officer/Principal Human Resources Officer | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Analyst Private Equity Investor Private Equity Investor Consultant / Advisor Private Equity Analyst | |
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania. | College/University | Masters Business Admin | |
| AGILENT TECHNOLOGIES, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
Jones Day LP
 Jones Day LP Miscellaneous Commercial ServicesCommercial Services Jones Day LP provides legal services. It offers services to the airlines, aviation, automotive, construction, energy, healthcare, insurance, media, pharmaceuticals, and telecommunication industries. The company was founded by Edwin J. Blandin and William Lowe Rice on March 1, 1893 and is headquartered in Cleveland, OH. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Notre Dame | College/University | Undergraduate Degree | |
Calistoga Pharmaceuticals, Inc.
 Calistoga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Calistoga Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The company was founded by Michael W. Gallatin, Roger Ulrich and Neil Giese in March 2006 and is headquartered in Tumwater, WA. | Pharmaceuticals: Major | Founder Founder | |
Incline Therapeutics, Inc.
 Incline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Incline Therapeutics, Inc. develops pharmaceutical products. The firm operates as hospital-focused specialty pharmaceutical company focused on the development of IONSYS (fentanyl iontophoretic transdermal system). The company was founded in 2009 and is headquartered in Seatle, WA. | Pharmaceuticals: Major | Founder Founder | |
| Stanford University | College/University | Undergraduate Degree Corporate Officer/Principal Masters Business Admin | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer General Counsel | |
| Western Michigan University | College/University | Graduate Degree | |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN. | College/University | Graduate Degree | |
| West Virginia State University | College/University | Corporate Officer/Principal | |
| West Virginia University | College/University | Doctorate Degree | |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Georgetown University | College/University | Undergraduate Degree Undergraduate Degree | |
| CADENCE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder | |
| VIRTUALSCOPICS INC | Miscellaneous Commercial Services | Director of Finance/CFO | |
| Ain Shams University | College/University | Doctorate Degree | |
MiraMedica, Inc.
 MiraMedica, Inc. Medical SpecialtiesHealth Technology MiraMedica, Inc. supplies, equipment and diagnostic imaging devices. It also supplies digital imaging devices. The company is located in Los Gatos, CA. | Medical Specialties | Founder | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| CelTor Biosystems, Inc. | Director of Finance/CFO | ||
Kaiser Associates, Inc.
 Kaiser Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Kaiser Associates, Inc. provides boutique strategy consulting services. The private company is based in Washington. Loren Eric Kaiser has been the CEO of the American company since 1999. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Pharmaceuticals: Generic | Director/Board Member Chief Tech/Sci/R&D Officer | |
| New York University School of Law | College/University | Graduate Degree | |
Nexcida Therapeutics, Inc.
 Nexcida Therapeutics, Inc. BiotechnologyHealth Technology Nexcida Therapeutics, Inc. operates in the field of infectious disease therapeutics. The company was founded by Yigong Ge and is headquartered in Menlo Park, CA. | Biotechnology | Chief Executive Officer | |
Outpost Medicine, Inc.
 Outpost Medicine, Inc. Pharmaceuticals: MajorHealth Technology Outpost Medicine LLC develops therapeutics for the treatment of urologic and gynecologic disorders. The company was founded by David Socks and Tachi Yamada in 2016 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Founder Founder | |
| MYOVANT SCIENCES LTD. | Biotechnology | Director of Finance/CFO Director/Board Member | |
| PROMETHEUS BIOSCIENCES, INC. | Biotechnology | Chairman Chief Operating Officer | |
Scout Bio, Inc.
 Scout Bio, Inc. Pharmaceuticals: MajorHealth Technology Scout Bio, Inc. operates as a biotechnology company that focuses on the innovation of pet medicine by delivering a pipeline of one-time therapeutics for major chronic pet health conditions. It also specializes in gene therapy, veterinary product development and biotechnology investment. The company was founded by James M. Wilson in 2016 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Chairman Chief Executive Officer Founder | |
Recida Therapeutics, Inc.
 Recida Therapeutics, Inc. BiotechnologyHealth Technology Recida Therapeutics, Inc. engages in the development of novel therapeutics. The company was founded by Yigong Ge, Aditya Kohli, and David A. Socks in 2016 and is headquartered in Menlo Park, CA. | Biotechnology | Founder Founder | |
| ARCUTIS BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
ReAlta Life Sciences, Inc.
 ReAlta Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services ReAlta Life Sciences, Inc. is a biotech company dedicated to harnessing the power of immune system through PIC1 technology. The company was founded in 2018 and is headquartered in Norfolk, VA. | Miscellaneous Commercial Services | Director/Board Member | |
| PASSAGE BIO, INC. | Biotechnology | Founder Founder Founder | |
Seraxis, Inc.
 Seraxis, Inc. Pharmaceuticals: MajorHealth Technology Part of Seraxis Pte Ltd., Seraxis, Inc. is a biotechnology company that specializes in developing a proprietary human stem cell line, sr1423, and manufacturing process to generate pancreatic islets that mimic native islets in purity and potency. The company is based in Germantown, MD. The company has also developed the seragraft device and other tools to enable survival and function of the islet replacement therapy in immunocompetent hosts. Seraxis aims to be the first to provide diabetics a clinical solution for glucose control and complete autonomy from insulin injections. The company was founded in 2013 by William L. Rust, who has been the CEO since 2013. | Pharmaceuticals: Major | Director/Board Member | |
| ICOSAVAX, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| HILLEVAX, INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
Eleusis Holdings Ltd.
 Eleusis Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Beckley Psytech Ltd., Eleusis Holdings Ltd. is a life science company based in London, UK. The British company is leading translational research in bold new directions and developing a broad and differentiated portfolio of drug candidates to address unmet needs within and beyond psychiatry. Eleusis is dedicated to transforming psychedelics into medicines, empowering patients, and facilitating access to care. The company was founded in 2017. The CEO is Shlomi Raz. Eleusis Holdings was acquired by Beckley Psytech Ltd. | Miscellaneous Commercial Services | Chairman | |
| Cadence Pharmaceuticals , Inc. | Founder | ||
Lassen Therapeutics LLC
 Lassen Therapeutics LLC Pharmaceuticals: MajorHealth Technology Lassen Therapeutics LLC operates as a therapeutic antibody company. It discovers and develops novel medicines to treat serious unmet medical needs. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Seraxis Holdings, Inc.
 Seraxis Holdings, Inc. Financial ConglomeratesFinance Seraxis Holdings, Inc. functions as an investment holding private company. The company is based in Germantown, MD. The CEO of the company is William L Rust. | Financial Conglomerates | Director/Board Member | |
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
Sudo Biosciences, Inc.
 Sudo Biosciences, Inc. Information Technology ServicesTechnology Services Sudo Biosciences, Inc. is a biopharmaceutical company that focuses on designing and developing innovative medicines to improve the lives of patients. Sudo Biosciences is based in Menlo Park, CA, and has operations in other locations. The company's primary focus is on developing treatments that target the tyrosine kinase 2 (TYK2) pseudokinase domain, which is a crucial mediator in cytokine signaling pathways that have been associated with various immune-mediated inflammatory conditions. The CEO of the company is Scott A. Byrd. | Information Technology Services | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 44 |
| Niederlande | 3 |
| Vereinigtes Königreich | 3 |
| Japan | 2 |
| Ägypten | 2 |
Sektoral
| Health Technology | 29 |
| Consumer Services | 11 |
| Commercial Services | 6 |
| Finance | 3 |
| Health Services | 2 |
Operativ
| Director/Board Member | 105 |
| Corporate Officer/Principal | 48 |
| Independent Dir/Board Member | 36 |
| Founder | 29 |
| Chairman | 25 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| James Topper | 49 |
| Tadataka Yamada | 36 |
| David Socks | 24 |
| Roger Ulrich | 17 |
| Michael Cola | 17 |
| Heidi Fields | 12 |
| Jonathan Edwards | 12 |
| Frank Karbe | 11 |
| Molly Henderson | 10 |
| Terrie Curran | 10 |
| Aditya Kohli | 10 |
| Todd Branning | 9 |
| Mark Stenhouse | 7 |
| Asit Parikh | 6 |
| Azmi Nabulsi | 6 |
- Börse
- Insiders
- Martin J. Gilligan
- Unternehmensverbindungen
